Detalles de la búsqueda
1.
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis.
J Pharmacol Exp Ther
; 360(1): 117-128, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27811173
2.
Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
Neurology
; 89(21): 2176-2186, 2017 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-29070667
3.
Further Evaluation of Mechanisms Associated with the Antidepressantlike Signature of Scopolamine in Mice.
CNS Neurol Disord Drug Targets
; 16(4): 492-500, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28294051
4.
In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu2/3 receptor antagonist.
Neuropharmacology
; 115: 100-114, 2017 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26748052
5.
Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8 Through Investigations of TARP γ-8 Null Mice§.
CNS Neurol Disord Drug Targets
; 14(5): 612-26, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25921737
6.
LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
Neuropharmacology
; 77: 131-44, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24071566
Resultados
1 -
6
de 6
1
Próxima >
>>